Certara, Inc. (NASDAQ:CERT) Given Average Rating of “Moderate Buy” by Analysts

Shares of Certara, Inc. (NASDAQ:CERT) have been assigned a consensus recommendation of “Moderate Buy” from the eight analysts that are presently covering the company, Marketbeat Ratings reports. Four analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $15.83.

A number of equities analysts recently commented on the company. TD Cowen assumed coverage on Certara in a research note on Thursday, February 27th. They issued a “buy” rating and a $16.00 price target for the company. Robert W. Baird decreased their target price on Certara from $18.00 to $13.00 and set a “neutral” rating for the company in a research report on Tuesday, November 5th. William Blair reissued a “market perform” rating on shares of Certara in a research report on Thursday, February 27th. Stephens reaffirmed an “overweight” rating and issued a $17.00 price objective on shares of Certara in a report on Thursday, February 27th. Finally, Barclays boosted their target price on shares of Certara from $12.00 to $13.00 and gave the company an “equal weight” rating in a research note on Friday.

Hedge Funds Weigh In On Certara

Several hedge funds and other institutional investors have recently modified their holdings of CERT. Vanguard Group Inc. increased its holdings in shares of Certara by 0.3% in the 4th quarter. Vanguard Group Inc. now owns 12,437,089 shares of the company’s stock worth $132,455,000 after acquiring an additional 38,068 shares during the period. Wasatch Advisors LP increased its stake in shares of Certara by 22.4% in the third quarter. Wasatch Advisors LP now owns 9,015,941 shares of the company’s stock valued at $105,577,000 after purchasing an additional 1,651,076 shares during the period. ArrowMark Colorado Holdings LLC increased its stake in shares of Certara by 164.2% in the fourth quarter. ArrowMark Colorado Holdings LLC now owns 6,213,278 shares of the company’s stock valued at $66,171,000 after purchasing an additional 3,861,674 shares during the period. Geneva Capital Management LLC boosted its position in shares of Certara by 0.7% during the third quarter. Geneva Capital Management LLC now owns 5,510,209 shares of the company’s stock worth $64,525,000 after buying an additional 37,392 shares during the period. Finally, Teacher Retirement System of Texas grew its holdings in Certara by 13.9% in the 4th quarter. Teacher Retirement System of Texas now owns 4,557,951 shares of the company’s stock worth $48,542,000 after buying an additional 557,348 shares in the last quarter. Institutional investors and hedge funds own 73.96% of the company’s stock.

Certara Price Performance

Shares of CERT stock opened at $11.94 on Thursday. The firm has a fifty day moving average of $12.48 and a two-hundred day moving average of $11.63. The firm has a market cap of $1.92 billion, a P/E ratio of -59.70, a P/E/G ratio of 9.29 and a beta of 1.57. Certara has a 1-year low of $9.41 and a 1-year high of $19.87. The company has a debt-to-equity ratio of 0.28, a current ratio of 2.86 and a quick ratio of 2.86.

About Certara

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.